Xinpei Yu
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Osimertinib plus anlotinib in untreated, EGFR-mutated, advanced non-small-cell lung cancer with concurrent alterations: a multicenter phase II study.
Journal: The oncologist
Published: March 18, 2026
MicroRNA-23a-3p influences the molecular mechanism of gastric cancer cells via CCL22/PI3K/Akt axis.
Journal: Bioengineered
Published: December 07, 2021
Loss of KMT2D induces prostate cancer ROS-mediated DNA damage by suppressing the enhancer activity and DNA binding of antioxidant transcription factor FOXO3.
Journal: Epigenetics
Published: June 25, 2019
Regulation of ELL2 stability and polyubiquitination by EAF2 in prostate cancer cells.
Journal: The Prostate
Published: February 07, 2018
XB130 is overexpressed in prostate cancer and involved in cell growth and invasion.
Journal: Oncotarget
Published: January 27, 2016
Regulation of tumor suppressor EAF2 polyubiquitination by ELL1 and SIAH2 in prostate cancer cells.
Journal: Oncotarget
Published: October 06, 2015
Inhibition of mTOR sensitizes breast cancer stem cells to radiation-induced repression of self-renewal through the regulation of MnSOD and Akt.
Journal: International journal of molecular medicine
Published: July 24, 2015
Pristimerin overcomes adriamycin resistance in breast cancer cells through suppressing Akt signaling.
Journal: Oncology letters
Published: January 03, 2015
miR-141 regulates TGF-β1-induced epithelial-mesenchymal transition through repression of HIPK2 expression in renal tubular epithelial cells.
Journal: International journal of molecular medicine
Published: July 23, 2014
Showing 1-11 of 11
Last Updated: 09/26/2026